Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors: an exploratory study from Spanish GETH/TC Centers.

Datos básicos

Protocolo:
TORMENT
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2025
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

GRUPO ESPAÑOL DE TRASPLANTES HEMATOPOYÉTICOS Y TERAPIA CELULAR (GETH)

Resultados del Ensayo Clínico


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT.

Esteve, Jordi; (...); Ciceri, Fabio

Article. 10.1002/ajh.27647. 2025


Assessment of the Immunodeficiency Scoring Index for predicting outcomes after Respiratory Syncytial Virus infection in Allogeneic Stem Cell Transplant recipients.: ISI performance for RVS infections after allo-HCT.

Mico-Cerda, Mireia; (...); Pinana, Jose Luis

Article. 10.1016/j.jtct.2025.02.012. 2025


Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors after Allogeneic Stem Cell Transplant?

Pinana, Jose Luis; (...); Solano, Carlos

Article. 10.1093/cid/ciae602. 2024

  • Open Access.

Cost-effectiveness and cost-utility analysis of haemate-P versus other von willebrand disease treatments in Spain.

Megias-Vericat, Juan E; (...); Yan, Songkai

Article. 10.1080/13696998.2025.2474886. 2025


Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.

Bastos-Oreiro, Mariana; (...); Barba, Pere

Article. 10.1002/hem3.70077. 2025


Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.

Chorao, Pedro; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2024.12.006. 2024

  • Open Access.

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Camacho-Arteaga, Lina; (...); Agusti, Antonia

Article. 10.1001/jamanetworkopen.2024.61683. 2025


Multimodal analysis identifies microbiome changes linked to stem cell transplantation-associated diseases

Artacho, Alejandro; (...); Ubeda, Carles

Article. 10.1186/s40168-024-01948-0. 2024

  • Open Access.

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model

Ferrer-Lores, Blanca; (...); Alberich-Bayarri, Angel

Article. 10.1186/s13550-024-01172-9. 2024

  • Open Access.

Campos de Estudio

Compartir